Exactech Broadens Spine Portfolio with Launch of Anchored Anterior Cervical Interbody Device at NASS 2015
October 13 2015 - 9:29AM
Business Wire
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder and spine,
announced today the launch of the new Acapella® One Cervical Spacer
System with integrated anchors during the North American Spine
Society Annual Meeting (NASS) in Chicago, IL, this week. Exactech
will feature an educational exhibit, booth #1033, during the
meeting.
With the introduction of Acapella One, a cervical cage with
integrated anchors, surgeons can restore disc height while
providing integrated fixation to prevent device migration during
anterior cervical spinal fusions. The unique design of the cage
allows for single-step deployment of both the integrated anchors
simultaneously, therefore simplifying the overall procedure.
After completing the first surgery, Anders Cohen, DO said, “I
have been very pleased with my initial clinical results using the
Acapella One cage. We all agreed that it was important to design an
implant that would be simple to implant at any level, and it
accomplished that goal today.”
Exactech designed the Acapella system in collaboration with a
surgeon team including Dr. Cohen, Steven Bailey, MD and Troy
Trimble, DO. Together, they created simplified instrumentation
designed to minimize surgical time and instrument processing. The
system includes a wide range of sizes to accommodate the patient’s
own unique anatomy. The device comes in two footprints, three
sagittal profiles and six heights for more than 36 size
combinations.
"Exactech is focused on providing a simplified technique for
surgeons and the potential for reduced operating time for
patients," said Bruce Thompson, Sr. Vice President and General
Manager of Spine and Biologics at Exactech. “We are pleased with
the early results reported with Acapella One, which we believe will
deliver on both of these goals.”
The successful pilot launch of Acapella One marks another
milestone in the continued development of innovative products
by Exactech Spine. The system rounds out Exactech’s anterior
cervical offerings, including the newly released Ambassador™
Cervical plate, which surgeons a wide range of options for
performing cervical fusion. Surgeons can learn more about the
Exactech Spine at www.ExactechSpine.com.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151013006113/en/
Exactech, Inc.Investor contactsJody Phillips,
352-377-1140Executive Vice President of Finance & Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail:EXAC@hawkassociates.comorMedia contactPriscilla
Bennett, 352-377-1140Vice President, Corporate & Marketing
Communication
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024